Elon Musk's Neuralink says it has FDA approval for first human clinical study
Summary by
ChatGPT
ChatGPT- Elon Musk's brain-implant company, Neuralink, has received FDA approval to begin its first-in-human clinical study after initially facing rejection due to safety concerns.
- The implant aims to treat conditions such as paralysis and blindness through direct brain-computer interfacing.
- The approval represents an important first step for the company's technology and comes as U.S. lawmakers raise concerns over animal testing and experimental procedures at Neuralink.
Published 14 days ago · S F, United States
News Articles
More
Filters
Filters
Time & Location
Sources are mostly out of (0)
Bias Distribution
44% of the sources are Center
+32
+58
+22
+6
L 27%
C 45%
R 28%
See less detail
